Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FREDUN PHARMA vs SEQUENT SCIENTIFIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FREDUN PHARMA SEQUENT SCIENTIFIC FREDUN PHARMA/
SEQUENT SCIENTIFIC
 
P/E (TTM) x 18.0 184.2 9.8% View Chart
P/BV x 2.7 8.7 30.5% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FREDUN PHARMA   SEQUENT SCIENTIFIC
EQUITY SHARE DATA
    FREDUN PHARMA
Mar-24
SEQUENT SCIENTIFIC
Mar-24
FREDUN PHARMA/
SEQUENT SCIENTIFIC
5-Yr Chart
Click to enlarge
High Rs1,249155 803.5%   
Low Rs65070 931.5%   
Sales per share (Unadj.) Rs740.854.9 1,348.9%  
Earnings per share (Unadj.) Rs33.2-1.2 -2,799.8%  
Cash flow per share (Unadj.) Rs41.31.3 3,227.9%  
Dividends per share (Unadj.) Rs0.700-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs255.123.2 1,098.5%  
Shares outstanding (eoy) m4.70249.43 1.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.1 62.5%   
Avg P/E ratio x28.6-94.9 -30.1%  
P/CF ratio (eoy) x23.088.0 26.1%  
Price / Book Value ratio x3.74.8 76.7%  
Dividend payout %2.10-   
Avg Mkt Cap Rs m4,46228,090 15.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1252,506 5.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,48213,697 25.4%  
Other income Rs m9110 8.4%   
Total revenues Rs m3,49113,807 25.3%   
Gross profit Rs m380440 86.3%  
Depreciation Rs m38615 6.2%   
Interest Rs m137481 28.4%   
Profit before tax Rs m215-546 -39.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m58-250 -23.3%   
Profit after tax Rs m156-296 -52.8%  
Gross profit margin %10.93.2 339.4%  
Effective tax rate %27.245.8 59.3%   
Net profit margin %4.5-2.2 -207.6%  
BALANCE SHEET DATA
Current assets Rs m2,5728,109 31.7%   
Current liabilities Rs m1,6686,270 26.6%   
Net working cap to sales %26.013.4 193.3%  
Current ratio x1.51.3 119.2%  
Inventory Days Days59 53.8%  
Debtors Days Days68089 760.2%  
Net fixed assets Rs m5046,392 7.9%   
Share capital Rs m47499 9.4%   
"Free" reserves Rs m1,1525,294 21.8%   
Net worth Rs m1,1995,793 20.7%   
Long term debt Rs m1281,427 9.0%   
Total assets Rs m3,07614,620 21.0%  
Interest coverage x2.6-0.1 -1,885.0%   
Debt to equity ratio x0.10.2 43.3%  
Sales to assets ratio x1.10.9 120.8%   
Return on assets %9.51.3 753.2%  
Return on equity %13.0-5.1 -254.9%  
Return on capital %26.5-0.9 -2,911.3%  
Exports to sales %22.31.4 1,626.3%   
Imports to sales %0.30.6 43.7%   
Exports (fob) Rs m777188 413.4%   
Imports (cif) Rs m981 11.1%   
Fx inflow Rs m777188 413.4%   
Fx outflow Rs m981 11.1%   
Net fx Rs m768107 717.9%   
CASH FLOW
From Operations Rs m-4306 -1.4%  
From Investments Rs m-76-59 129.0%  
From Financial Activity Rs m60-14 -416.5%  
Net Cashflow Rs m-21232 -9.0%  

Share Holding

Indian Promoters % 48.9 0.0 -  
Foreign collaborators % 0.0 52.8 -  
Indian inst/Mut Fund % 1.6 16.4 9.7%  
FIIs % 0.0 6.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.1 47.2 108.1%  
Shareholders   8,018 154,603 5.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FREDUN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on FREDUN PHARMA vs SEQUENT SCIENTIFIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

FREDUN PHARMA vs SEQUENT SCIENTIFIC Share Price Performance

Period FREDUN PHARMA SEQUENT SCIENTIFIC S&P BSE HEALTHCARE
1-Day 0.25% 5.00% 1.23%
1-Month -5.88% 12.52% -0.24%
1-Year -21.38% 85.27% 43.62%
3-Year CAGR 13.26% 5.38% 20.35%
5-Year CAGR 25.63% 25.44% 26.24%

* Compound Annual Growth Rate

Here are more details on the FREDUN PHARMA share price and the SEQUENT SCIENTIFIC share price.

Moving on to shareholding structures...

The promoters of FREDUN PHARMA hold a 48.9% stake in the company. In case of SEQUENT SCIENTIFIC the stake stands at 52.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FREDUN PHARMA and the shareholding pattern of SEQUENT SCIENTIFIC.

Finally, a word on dividends...

In the most recent financial year, FREDUN PHARMA paid a dividend of Rs 0.7 per share. This amounted to a Dividend Payout ratio of 2.1%.

SEQUENT SCIENTIFIC paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of FREDUN PHARMA, and the dividend history of SEQUENT SCIENTIFIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq(Pre-Open)

Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.